InsiderClue
Insiders · Profile

Seehra Jasbir

CHIEF EXECUTIVE OFFICER at Keros Therapeutics. Filing since 13 Apr 2020. CIK 0001732369

Company
Date
Role
Action
Shares
Amount
Of holding
KROS Keros Therapeutics, Inc.
19 Feb 2026
CHIEF EXECUTIVE OFFICER
Sold at will
7,015
$113.43K
1.8%
KROS Keros Therapeutics, Inc.
13 Apr 2020
Chief Executive Officer
Bought
20,000
$320.00K
8.9%
2 decisions on file.